


CARDIONOVUM
Medical Equipment Manufacturing • Bonn, North Rhine-Westphalia, Germany • 21-50 Employees
Company overview
| Headquarters | Am Bonner Bogen 2, Bonn, North Rhine-Westphalia 53227, DE |
| Phone number | +49492289090590 |
| Websites | |
| NAICS | 3391 |
| SIC | 384 |
| Founded | 2010 |
| Employees | 21-50 |
| Socials |
Key Contacts at CARDIONOVUM
Marcello Gramola
Director Of Cardiology
Paolo Silvestri
Clinical Research Director
Giada Di Giacinto Barabaschi
Business Unit Director Coronary Line
Eduard Palop
Sales Director Asia Pacific And Middle East
Diego Squara
Business Unit Director Peripheral Line
Claudio Lina
Business Development Director Italy
Massimo Morero
Chief Technology Officer
Monika Mroczkiewicz
Quality And Regulatory Affairs Director
Tobias Hübner
Sales Director Dach
Liliana Monroy
Chief Executive Officer'S Assistant
CARDIONOVUM Email Formats
CARDIONOVUM uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cardionovum.com), used 87.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@cardionovum.com | 87.5% |
{first initial}.{last name} | j.doe@cardionovum.com | 12.5% |
About CARDIONOVUM
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The company’s pioneering range of DCBs is based on the SAFEPAX® paclitaxel coating matrix which has the lowest wash-off rates on the market. The company’s strong commitment to clinical research ensures a continually deepening and expanding evidence-base in support of the clinical benefits of our products. Pioneers in medical devices. The worldwide first CE-approved DCB. With the first DCB market introduction, CARDIONOVUM contributed significantly to the establishment of a new medical device therapy to treat coronary and peripheral artery disease effectively. CARDIONOVUM consists of R & D staff, with the longest and most profound experience, in developing clinically advanced DCB and DES cardiovascular devices. “Live Deserves the Best”
CARDIONOVUM revenue & valuation
| Annual revenue | $2,737,760 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $8,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
CARDIONOVUM has 17 employees across 9 departments.
Departments
Number of employees
Funding Data
CARDIONOVUM has never raised funding before.
CARDIONOVUM Tech Stack
Discover the technologies and tools that power CARDIONOVUM's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
JavaScript libraries
Tag managers
Cookie compliance
Security
Cookie compliance
UI frameworks
Analytics
Ecommerce
Video players
Frequently asked questions
4.8
40,000 users



